1091625-93-2

Upstream product

• 428818-08-0 3,4,6-tri-O-acetyl-2-deoxy-2-trichloroacetamido-α/β-D-glucopyranose trichloroacetimidate 
• 1091625-51-2 allyl (2,3,4,6-tetra-O-benzyl-α-D-glucopyranosyl)-(1->3)-(4-O-benzyl-α-L-rhamnopyranosyl)-(1->2)-3,4-di-O-benzyl-α-L-rhamnopyranoside 

Downstream Products

• 1091625-94-3 allyl (2-deoxy-2-trichloroacetamido-β-D-glucopyranosyl)-(1->2)-[2,3,4,6-tetra-O-benzyl-α-D-glucopyranosyl-(1->3)]-(4-O-benzyl-α-L-rhamnopyranosyl)-(1->2)-3,4-di-O-benzyl-α-L-rhamnopyranoside 

Relevant academic research and scientific papers

Glycoconjugates and use thereof as vaccine against Shigella flexneri serotype 3a and X

The present invention relates to compounds derived from sugars which reproduce the epitopes of Shigella flexneri serotypes 3a and X and to the use thereof for the preparation of vaccine compositions. More specifically, the subject matter of the present in

Efficient synthesis of six tri- to hexasaecharide fragments of shigella flexneri serotypes 3a and/or X O-antigen, including a study on acceptors containing N-trichloroacetylglucosamine versus N-acetylglucosamine

Six tri- to hexasaccharide fragments of the {2)-[α-D-Glcp-(1→3)] -α-L-Rhap-(1→2)-α-L-Rhap-(1→3)-[Ac→2] -α-L-Rhap-(1→3)-β-D-GlcpNAc-(1→}n polymer ([(E)ABAcCD]n) were synthesized as their propyl glycosides. All targets share